🇺🇸 FDA
Pipeline program

Olaparib, Olaparib, KEYTRUDA 25 mg/mL concentrate for solution for infusion

GEMCAD 2102

Phase 2 small_molecule active

Quick answer

Olaparib, Olaparib, KEYTRUDA 25 mg/mL concentrate for solution for infusion for Colorectal cancer is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Colorectal cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials